Results 31 to 40 of about 890,728 (306)

Primary Squamous Cell Carcinoma of the Liver: Case Report and Review of Literature

Case Reports in Oncology, 2022
Primary squamous cell carcinoma (SCC) of the liver is a rare cancer type. The overall survival of this cancer is short despite treatment and prognosis are poor.
Omar Fakhreddine, Yasser Fadlallah, Jawad Turfa, Mona Ali Hassan, Nathalie Chamseddine, Hazem I. Assi   +5 more
doaj   +1 more source

Oral contraceptives and primary liver cancer [PDF]

British Journal of Cancer, 1989
The relative risk for developing primary liver cancer in northern Italian users of oral contraceptives compared to matched controls was calculated based on reported cases in hospitals in the greater Milan area from 1984-1987. The incidence of and mortality from primary liver cancer as well as the prevalence of oral contraceptive usage have both been ...
C. La Vecchia, E. Negri, F. Parazzini
openaire   +2 more sources

Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting [PDF]

, 2017
<b><i>Background:</i></b> Stereotactic body radiation therapy (SBRT) is an advanced technique of external beam radiation therapy that delivers large ablative doses of radiation. In the past decade, many cancer centers have adopted
Ada Law, Lam, KO, Lee, AS, Sang Min Yoon, Cheng, JCH, Yoon, SM, Ka-On Lam, Yong Hu, Zhao-Chong Zeng, Jinsil Seong, Jason Chia-Hsien Cheng, Hu, Y, Zeng, ZC, Zhang, JY, Jian-Ying Zhang, Law, LYA, Ann-Shing Lee, Seong, J   +17 more
core   +3 more sources

Proteo-genomic characterization of virus-associated liver cancers reveals potential subtypes and therapeutic targets

Nature Communications, 2022
The molecular heterogeneity of primary liver cancer remains to be characterised. Here, the authors perform multi-omics analysis of 259 primary liver cancer tissues and identify three distinct molecular subtypes.
Masashi Fujita, Mei-Ju May Chen, Doris Rieko Siwak, Shota Sasagawa, Ayako Oosawa-Tatsuguchi, Koji Arihiro, Atsushi Ono, Ryoichi Miura, Kazuhiro Maejima, Hiroshi Aikata, Masaki Ueno, Shinya Hayami, Hiroki Yamaue, Kazuaki Chayama, Ju-Seog Lee, Yiling Lu, Gordon B. Mills, Han Liang, Satoshi S. Nishizuka, Hidewaki Nakagawa   +19 more
doaj   +1 more source

The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB

Frontiers in Pharmacology, 2023
Aim: To analyze the safety of immune checkpoint inhibitors in primary liver cancer patients and to identify the risk factors for immune-related adverse events (irAEs).Methods: The study enrolled 106 patients with primary liver cancer, including 81 with ...
Shike Lou, Zhujun Cao, Wanqing Chi, Xiaoyin Wang, Mingyang Feng, Lanyi Lin, Yezhou Ding, Kehui Liu, Lihong Qu, Gangde Zhao, Shisan Bao, Hui Wang   +11 more
doaj   +1 more source

Association of the presence of allergic disease with subsequent risk of liver cancer in a nationwide retrospective cohort among Koreans

Scientific Reports, 2022
A number of studies have proposed an inverse association between allergic diseases and risk of cancer, but only a few studies have specifically investigated the risk of primary liver cancer, including hepatocellular carcinoma (HCC) and intrahepatic ...
Ji Ah Kim, Sun Jae Park, Seulggie Choi, Jooyoung Chang, Seogsong Jeong, Joseph C.Ahn, Gyeongsil Lee, Joung Sik Son, Sang Min Park   +8 more
doaj   +1 more source

Interpretation on the Updated Points of Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)

Xiehe Yixue Zazhi, 2022
Since the publication of the Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2019 Edition), many new high-level evidence in line with evidence-based medicine has emerged in the diagnosis and treatment of liver cancer at home and ...
JIN Bao, DU Shunda, MAO Yilei, SANG Xinting   +3 more
doaj   +1 more source

Hepatocellular Carcinoma: Hope and Challenges [PDF]

Liaquat National Journal of Cancer Care, 2021
Cancer of the liver and intrahepatic bile ducts is the sixth commonest cancer in the world, with approximately 841,000 new cases reported in 2018.
Misbah Tahir
doaj   +1 more source

Regulatory Mechanism of PD-L1 Expression in Primary Liver Cancer

Zhongliu Fangzhi Yanjiu, 2021
The application of immunotherapy has become a hot spot in tumor research currently. In particular, immune checkpoint inhibitors have played an important role in the treatment of advanced unresectable primary liver cancer.
LI Shenghao, SHI Xinli
doaj   +1 more source

Next-Generation Sequencing: Application in Liver Cancer—Past, Present and Future?

, 2012
Hepatocellular Carcinoma (HCC) is the third most deadly malignancy worldwide characterized by phenotypic and molecular heterogeneity. In the past two decades, advances in genomic analyses have formed a comprehensive understanding of different underlying ...
Marquardt, Jens U, Andersen, Jesper B, Jesper B. Andersen, Jens U. Marquardt   +3 more
core   +1 more source